期刊文献+

人钙周期素结合蛋白 (hCacyBP)基因的原核表达及其鼠抗血清的制备 被引量:2

Prokaryotic expression of human calcyclin-binding protein and preparation of mouse polyclonal antibody against hCacyBP
在线阅读 下载PDF
导出
摘要 目的 :原核表达hCacyBP并制备小鼠抗hCacyBP多克隆抗体。观察该蛋白组织分布情况 ,研究其可能在胃癌多药耐药形成中的作用。方法 :将hCacyBP基因的全编码区克隆进原核表达载体pET2 8a中 ,转化E .coli,以IPTG诱导重组目的蛋白的表达。以纯化的重组目的蛋白作为免疫原免疫小鼠 ,制备相应的多克隆抗体。以Westernblot法检测hCacyBP在兔 10种组织的表达情况 ;以Westernblot和免疫组化染色法检测hCa cyBP在胃癌耐药细胞SGC790 1/VCR及其亲本药敏细胞SGC790 1中的表达和分布。结果 :成功地表达重组目的蛋白并制备了小鼠抗hCacyBP的多克隆抗体 ,Westernblot分析显示 ,hCacyBP在兔的 10种组织中均有表达 ,在脑和肝组织中表达略高 ;hCacyBP在胃癌耐药细胞SGC790 1/VCR及其亲本药敏细胞SGC790 1中的表达未见明显差异。结论 :CacyBP是在多种组织中广泛表达的一种蛋白质。制备的小鼠抗hCa cyBP多克隆抗体特异性较高 ,为进一步研究hCacyBP的功能提供了工具。 AIM: To express hCacyBP in E.coli and prepare mouse polyclonal antib ody against hCacyBP so as to study tissue distribution of hCacyBP and evaluate i ts role during formation of multidrug resistance to gastric cancer. MET HODS: hCacyBP gene was subcloned into an expression vector pET28a, and then the recombinant vector was transformed into E.coli BL21. The recombinan t protein was expressed in BL21 under IPTG induction. Using purified hCacyBP as immunogen, mouse polyclonal antibody against hCacyBP was prepared. hCacyBP was d etected by Western blot in 10 kinds of rabbit tissues. Expresseion and distribut ion of hCacyBP in SGC7901/VCR and SGC7901 cells were detected by Western blot an d immunohistochemical staining. RESULTS: hCacyBP was succes sfully expressed in E.coli. The Western blot analysis showed that hCacyBP wa s expressed in all 10 kinds of rabbit tissues, but expression of brain and liver tissues were higher as compared with other tissues. Expression and distribution of hCacyBP in both SGC7901/VCR and SGC7901 cells had no significant difference. CONCLUSION: CacyBP expressed widespreadly in varied tissues. Po lyclonal antibody against hCacyBP that we prepared has high specificity, which p rovides a powerful tool for studing the function of hCacyBP.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2004年第2期206-209,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目 (No .30 0 30 1 40)
关键词 人钙周期素结合蛋白 表达 多药耐药性 human calcyclin-binding protein expression m ultidrug resistance
  • 相关文献

参考文献10

  • 1Filipek A, Wojda U. P30, a novel target of mouse calcyclin(S100A6) [J]. BiochemJ, 1996, 320(Pt2): 302-306.
  • 2Filipek A, Kuznicki J. Moleeular cloning and expression of a mousebrain eDNA encoding a novel target of calcyclin [ J]. J Neurochem,1998, 70(5): 1793 - 1798.
  • 3Matsuzawa S, Reed JC. Siah-1, SIP and Ebi collaborate in a novelpathway for β-Catenin degradation linked to p53 response [ J ]. Molcell,2001,7(5):915-926.
  • 4Donato R. S100: a multigenic family of calcium-modulated proteins ofthe EF-hand type with intracellular and extracellular functional roles[J]. Int J Biochem Cell Biol, 2001, 33(7): 637-668.
  • 5Hg EC, Schafer BW. Expression pattern of S100 Calcium-binding proteins in human tumors [J]. Int J Cancer, 1996,68(3): 325 -332.
  • 6Hsieh HL, Schafer BW. Expression analysis of S100 proteins andRAGE in human tumors using tissue microarrays [ J ]. Biochem Biophys Res Commun, 2003, 307(2): 375 -381.
  • 7Crnogorar-Jurcevic T, Missiaglia E. Molecular alteration in pancreaticcarcinoma: expression profiling shows that dysregulated expression ofS100 genes is highly prevalent [ J ]. J Pathol, 2003, 201 ( 1 ):63 - 74.
  • 8Filipek A, Jastrzebska B. CacyBP/SIP, a calcyclin and siah-1-interacting protein, binds EF-hand proteins od the S100 family [J] . JBio Chem, 2002, 277(33): 28848-28852.
  • 9胡文华,尹芳,金晓航,樊代明.CacyBP编码基因对胃癌细胞多药耐药性形成的影响[J].中华肿瘤杂志,2002,24(5):426-429. 被引量:4
  • 10Takayama T, Shiozaki H. β-Catenin expression in human cancers[J]. Am J Pathol, 1999, 148(1): 39 -46.

二级参考文献8

  • 1Filipek A, Wojda U. p30, a novel protein target of mouse calcyclin (S100A6). Biochem J, 1996,320:585-587.
  • 2Filipek A, Kuznicki J. Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J Neurochem, 1998, 70: 1793-1798.
  • 3Jastrzebska B, Filipek A, Nowicka D, et al. Calcyclin (S100A6) binding protein (CacyBP) is higly expressed in brain neurons. J Histochem Cytochem, 2000, 48:1195-1202.
  • 4Belpomme D, Gauthier S, Pujade-Lauraine E, et al. Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma. Ann Oncol, 2000,11:1471-1476.
  • 5Brouillard F, Tondelier D, Edelman A, et al. Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells. Cancer Res, 2001,61:1693-1698.
  • 6Zeng FY, Gerke V, Gabius HJ. Identification of annexin Ⅱ, annexin Ⅵ and glyceraldehydes-3-phosphate dehydrogenase as calcyclin-binding proteins in bovine heart.Int J Biochem,1993,25:1019-1027.
  • 7Kordowska J, Stafford WF, Wang CL. Ca2+ and Zn2+ bind to different sites and induce different conformational changes in human calcyclin. Eur J Biochem, 1998,253:57-66.
  • 8Stradal TB, Gimona M. Ca2+-dependent association of S100A6 (Calcyclin) with the plasma membrane and the nuclear envelope. J Biol Chem ,1999,274:31593-31596.

共引文献4

同被引文献19

  • 1[1]Filikpek A,Wojda U.P30,a novel target of mouse calcyclin(S100A6).Biochem J,1996,320(Pt2):302 ~306
  • 2[2]Matsuzawa S,Reed JC.Siah-1,SIP,and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 response.Mol cell,2001,7(5):915 ~926
  • 3[4]Heizmann CW,Fritz G,Schafer BW.S100 protein:structure,functions and pathology.Front Biosci,2002,7:d1356~ 1368
  • 4[5]Schlagenhauff B,Schittek B.Significance of serum protein S100 levels in screening for melanoma metastasis:does protein S100 enable early detection of melanoma recurrence?Melanoma Res,2000,10(5):451 ~459
  • 5[6]Jenkinson SR,Barraclough R.S100A4 regulates cell motility and invasion invasion in an in vitro model for breast cancer metastasis.Br J Cancer,2004,90(1):253 ~262
  • 6[7]Komatsu K,Murata K.Expression of S100A6 and S100A4 in matched asmoles of human colorectal mucosa,primary colorectal adenocarcinoma and liver metastases.Oncology,2002,59(2):192 ~200
  • 7[8]Clevers H.Wnt breakers in colon cancer.Cancer Cell,2004,5(1):5 ~6
  • 8[9]Cheshire DR,Isaacs WB.Beta-catenin signaling in prostate cancer:an early perspective.Endocr Relat Cancer.2003,10(4):537 ~560
  • 9[10]Cong F,Zhang J.A protein knockdown strategy to study the function of beta-catenin in tumorigenesis.BMC Mol Bilo,2003,4(1):10
  • 10Filipek A.S100A6 and CacyBP/SIP-two proteins discovered in Ehrlich ascites tumor cells that are potentially involved in the degradation of beta-catenin.Chemotherapy,2006,52:32-34.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部